Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis

NCT00956098 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Fibrosis
Liver Cirrhosis

Interventions

DRUG: oltipraz
DRUG: placebo

Sponsor

HK inno.N Corporation